Of interest, it has been reported that aPS/PT positivity represents a risk factor of RPL even in the absence of a clear diagnosis of APS, hence suggesting an independent pathogenic activity of these antibodies [27]. The gene discussed is F2; the disease is autoimmune polyendocrinopathy.